DEA: Methylstenbolone

Anthony Roberts filed this request with the Drug Enforcement Administration of the United States of America.
Tracking #

17-00638-F

Status
Completed

Communications

From: anthony roberts

To Whom It May Concern:

This is a request under the Freedom of Information Act.

I am seeking DEA documents that mention 2,17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-one (aka Methylstenbolone). I would like adverse reaction reports, both consumer complaints and industry complaints, that mention this compound in a dietary supplement or other product . I would also like lab tests (whether conducted by the DEA, at the DEA's behest, or simply forwarded to the DEA) that have revealed or sought to reveal the presence of this compound in any products. I am also seeking any enforcement actions that have resulted from any of the aforementioned complaints, lab tests, or adverse reaction reports. In addition I am seeking internal and external emails that mention this compound.

I am a professional member of the media (Society of Professional Journalists member number available upon reqest). The documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

anthony roberts

From: DEA.FOIA

Hello Mr. Roberts

Please find attached a copy of our acknowledgement letter regarding your request for "DEA documents that mention 2, 17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-one aka Methylstenbolone to include adverse reaction reports, consumer complaints and industry complaints, that mention this compound in a dietary supplement or other product, etc.)." Please be advised that your request has been opened and assigned FOIA case number 17-00638-F. Please include this case number when corresponding with this office. If you have any questions or concerns please regarding this matter, please feel to contact our Customer Service Hotline at 202-307-7596.

Respectfully yours,
Deshelia Wallace
Government Information Specialist
Freedom of Information/Privacy Act Unit (SARF)
(Desk) 202-307-4264; (fax) 202-307-8556
FOIA/PA Main Phone Line 202-307-7596

From: Drug Enforcement Administration

An interim response, stating the request is being processed.

From: DEA.FOIA

Hello Mr. Roberts

This email is in response to your email below requesting a follow up on FOIA case 17-00638-F. Please be advised that your request has been thoroughly reviewed and tasking memoranda have been forwarded to the Diversion Control Division (DC) which is the office within the DEA that would be best suited, or would likely maintain the records that are responsive to this request. Please be assured that once we are in possession of the records, if any, your request will be processed as expeditiously as possible. Your patience in this matter is appreciated. If you have any further questions or concerns please feel to contact our Customer Service Hotline at 202-307-7596 or Government Information Specialist Denise Gutrick at 202-307-7628.

Respectfully yours,
Deshelia Wallace
Government Information Specialist
Freedom of Information/Privacy Act Unit (SARF)
(Desk) 202-307-4264; (fax) 202-307-8556
FOIA/PA Main Phone Line 202-307-7596

From: Drug Enforcement Administration

A copy of documents responsive to the request.

Files

pages

Close